The endothelin system and endothelin receptor antagonists

Sumner, 1992, Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction., Br J Pharmacol, 107, 858, 10.1111/j.1476-5381.1992.tb14537.x

Clozel, 1992, The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo., Biochem Biophys Res Commun, 186, 867, 10.1016/0006-291X(92)90826-7

Tirapelli, 2005, Functional characterization and expression of endothelin receptors in rat carotid artery: involvement of nitric oxide, a vasodilator prostanoid, and the opening of K channels in ETB-induced relaxation., Br J Pharmacol, 146, 903, 10.1038/sj.bjp.0706388

Fukuroda, 1994, Clearance of circulating endothelin-1 by ETB receptors in rats., Biochem Biophys Res Commun, 199, 1461, 10.1006/bbrc.1994.1395

Goddard, 2004, Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade., Circulation, 109, 1186, 10.1161/01.CIR.0000118499.69469.51

Strachan, 1999, Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy men., Hypertension, 33, 581, 10.1161/01.HYP.33.1.581

Hoffman, 2000, Mechanisms of big endothelin-1-induced diuresis and natriuresis: role of ET(B) receptors., Hypertension, 35, 732, 10.1161/01.HYP.35.3.732

Boesen, 2010, Cooperative role of ETA and ETB receptors in mediating the diuretic response to intramedullary hyperosmotic NaCl infusion., Am J Physiol Renal Physiol, 299, F1424, 10.1152/ajprenal.00015.2010

Ergul, 2000, Hypertension in black patients: an emerging role of the endothelin system in salt-sensitive hypertension., Hypertension, 36, 62, 10.1161/01.HYP.36.1.62

Rubin, 2002, Bosentan therapy for pulmonary arterial hypertension., N Engl J Med, 346, 896, 10.1056/NEJMoa012212

Battistini, 2006, Profile of past and current clinical trials involving endothelin receptor antagonists: the novel -sentan class of drug., Exp Biol Med, 231, 653

Weber, 2009, A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial., Lancet, 374, 1423, 10.1016/S0140-6736(09)61500-2

Battistini, 2005, Cgs 35601, a triple inhibitor of angiotensin converting enzyme, neutral endopeptidase and endothelin converting enzyme., Cardiovasc Drug Rev, 23, 317, 10.1111/j.1527-3466.2005.tb00175.x

Mann, 2010, Avosentan for overt diabetic nephropathy., J Am Soc Nephrol, 21, 527, 10.1681/ASN.2009060593

Reriani, 2010, Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis., Circulation, 122, 958, 10.1161/CIRCULATIONAHA.110.967406

Kohan, 2011, Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy., J Am Soc Nephrol, 22, 763, 10.1681/ASN.2010080869

Galie, 2011, Liver toxicity of sitaxsentan in pulmonary arterial hypertension., Eur Heart J, 32, 386

Forbes, 2001, Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function., Kidney Int, 59, 1333, 10.1046/j.1523-1755.2001.0590041333.x

Saleh, 2011, Distinct actions of endothelin A-selective versus combined endothelin AB receptor antagonists in early diabetic kidney disease., J Pharmacol Exp Ther, 338, 263, 10.1124/jpet.111.178988

Sasser, 2007, Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism., J Am Soc Nephrol, 18, 143, 10.1681/ASN.2006030208

Watson, 2010, The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice., Diabetologia, 53, 192, 10.1007/s00125-009-1540-3

Wenzel, 2009, Avosentan reduces albumin excretion in diabetics with macroalbuminuria., J Am Soc Nephrol, 30, 655, 10.1681/ASN.2008050482

Ramzy, 2006, Elevated endothelin-1 levels impair nitric oxide homeostasis through a PKC-dependent pathway., Circulation, 114, I319, 10.1161/CIRCULATIONAHA.105.001503

Cardillo, 1999, Insulin stimulates both endothelin and nitric oxide activity in the human forearm., Circulation, 100, 820, 10.1161/01.CIR.100.8.820

Weil, 2011, Enhanced endothelin-1 system activity with overweight and obesity., Am J Physiol Heart Circ Physiol, 301, H689, 10.1152/ajpheart.00206.2011

Cardillo, 2002, Increased activity of endogenous endothelin in patients with type II diabetes mellitus., Circulation, 106, 1783, 10.1161/01.CIR.0000032260.01569.64

Amiri, 2004, Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction., Circulation, 110, 2233, 10.1161/01.CIR.0000144462.08345.B9

Amiri, 2008, Vascular inflammation in absence of blood pressure elevation in transgenic murine model overexpressing endothelin-1 in endothelial cells., J Hypertens, 26, 1102, 10.1097/HJH.0b013e3282fc2184

Barton, 1998, Endothelin eta receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice., Proc Natl Acad Sci USA, 95, 14367, 10.1073/pnas.95.24.14367

Ihling, 1996, Endothelin-1-like immunoreactivity in human atherosclerotic coronary tissue: a detailed analysis of the cellular distribution of endothelin-1., J Pathol, 179, 303, 10.1002/(SICI)1096-9896(199607)179:3<303::AID-PATH585>3.0.CO;2-9

Lerman, 1991, Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis., N Engl J Med, 325, 997, 10.1056/NEJM199110033251404

Winkles, 1993, Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries., Biochem Biophys Res Commun, 191, 1081, 10.1006/bbrc.1993.1327

Minamino, 1997, Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis., Circulation, 95, 221, 10.1161/01.CIR.95.1.221

Simeone, 2011, Vascular gene expression in mice overexpressing human endothelin-1 targeted to the endothelium., Physiol Genomics, 43, 148, 10.1152/physiolgenomics.00218.2009

Watts, 2010, Endothelin receptors: whats new and what do we need to know Am J Physiol Regul Integr Comp P, hysiol, 298, R254